Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
178, P. 117248 - 117248
Published: Aug. 3, 2024
Exosome-nanoparticle
hybrid
nanoplatforms,
can
be
prepared
by
combining
exosomes
with
different
types
of
nanoparticles.
The
main
purpose
nanoparticles
is
to
overcome
the
limitations
using
each
them
as
drug
delivery
systems.
Using
for
has
some
limitations,
such
high
immunogenicity,
poor
cellular
uptake,
low
biocompatibility,
cytotoxicity,
stability,
and
rapid
clearance
immune
cells.
However,
systems
also
its
own
drawbacks,
encapsulation
efficiency,
production
yield,
inability
load
large
molecules.
These
addressed
utilizing
nanoplatforms.
Additionally,
use
allows
targeted
within
system.
Exosome-inorganic/organic
may
used
both
therapy
diagnosis
in
future.
This
lead
development
personalized
medicine
there
are
a
few
challenges
associated
this.
Surface
modifications,
adding
functional
groups,
surface
charge
adjustments,
preparing
desired
size
crucial
possibility
exosome-nanoparticle
hybrids.
Additional
successful
implementation
platforms
medical
treatments
diagnostics
include
scaling
up
manufacturing
process
ensuring
consistent
quality
reproducibility
across
various
batches.
review
focuses
on
discusses
preparation
loading
methods
these
Furthermore,
potential
applications
nanocarriers
drug/gene
delivery,
disease
treatment
diagnosis,
cell/tissue
imaging
explained.
Cell Communication and Signaling,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: April 13, 2023
Abstract
Extracellular
vesicles
(EVs)
are
small,
membrane-bound
structures
that
released
from
cells
into
the
surrounding
environment.
These
can
be
categorized
as
exosomes,
microvesicles,
or
apoptotic
vesicles,
and
they
play
an
essential
role
in
intercellular
communication.
attracting
significant
clinical
interest
offer
potential
for
drug
delivery,
disease
diagnosis,
therapeutic
intervention.
To
fully
understand
regulation
of
communication
through
EVs,
it
is
to
investigate
underlying
mechanisms.
This
review
aims
provide
a
summary
current
knowledge
on
communications
involved
EV
targeting,
binding,
uptake,
well
factors
influence
these
interactions.
include
properties
cellular
environment,
recipient
cell.
As
field
EV-related
continues
expand
techniques
improve,
we
expect
uncover
more
information
about
this
complex
area,
despite
limitations
our
knowledge.
Molecular Therapy,
Journal Year:
2023,
Volume and Issue:
31(5), P. 1231 - 1250
Published: Feb. 20, 2023
Extracellular
vesicles
(EVs)
are
gaining
increasing
attention
for
diagnostic
and
therapeutic
applications
in
various
diseases.
These
natural
nanoparticles
benefit
from
favorable
safety
profiles
unique
biodistribution
capabilities,
rendering
them
attractive
drug-delivery
modalities
over
synthetic
analogs.
However,
the
widespread
use
of
EVs
is
limited
by
technological
shortcomings
biological
knowledge
gaps
that
fail
to
unravel
their
heterogeneity.
An
in-depth
understanding
biogenesis
crucial
unlocking
full
potential.
Here,
we
explore
how
about
EV
can
be
exploited
bioengineering
load
protein
or
nucleic
acid
cargos
into
onto
EVs.
We
summarize
more
than
75
articles
discuss
findings
on
formation
composition
exosomes
microvesicles,
revealing
multiple
pathways
may
stimulation
and/or
cargo
dependent.
Our
analysis
further
identifies
key
regulators
loading
this
integrated
develop
engineered
biotherapeutics.
Journal of Extracellular Vesicles,
Journal Year:
2022,
Volume and Issue:
11(1)
Published: Jan. 1, 2022
Previously
thought
to
be
nothing
more
than
cellular
debris,
extracellular
vesicles
(EVs)
are
now
known
mediate
physiological
and
pathological
functions
throughout
the
body.
We
understand
about
their
capacity
transfer
nucleic
acids
proteins
between
distant
organs,
interaction
of
surface
with
target
cells,
role
vesicle-bound
lipids
in
health
disease.
To
date,
most
observations
have
been
made
reductionist
cell
culture
systems,
or
as
snapshots
from
patient
cohorts.
The
heterogenous
population
produced
vivo
likely
act
concert
both
beneficial
detrimental
effects.
EVs
play
crucial
roles
pathogenesis
diseases,
cancer
neurodegenerative
disease,
well
maintenance
system
organ
homeostasis.
This
two-part
review
draws
on
expertise
researchers
working
field
EV
biology
aims
cover
functional
physiology
pathology.
Part
I
will
outline
normal
physiology.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(9), P. 4368 - 4368
Published: April 22, 2021
Seminal
plasma
(SP),
the
non-cellular
component
of
semen,
is
a
heterogeneous
composite
fluid
built
by
secretions
testis,
epididymis
and
accessory
sexual
glands.
Its
composition,
despite
species-specific
anatomical
peculiarities,
consistently
contains
inorganic
ions,
specific
hormones,
proteins
peptides,
including
cytokines
enzymes,
cholesterol,
DNA
RNA-the
latter
often
protected
within
epididymis-
or
prostate-derived
extracellular
vesicles.
It
beyond
question
that
SP
participates
in
diverse
aspects
sperm
function
pre-fertilization
events.
The
also
interacts
with
various
compartments
tubular
genital
tract,
triggering
changes
gene
prepares
for
an
eventual
successful
pregnancy;
thus,
it
ultimately
modulates
fertility.
Despite
these
concepts,
imperative
to
remember
SP-free
spermatozoa
(epididymal
washed
ejaculated)
are
still
fertile,
so
this
review
shall
focus
on
differences
between
vivo
roles
following
semen
deposition
female
those
regarding
additions
handled
artificial
reproduction,
cryopreservation,
from
insemination
vitro
fertilization.
This
attempts,
our
own
results
model
animal
species,
critically
summarize
current
knowledge
reproductive
played
components,
particularly
which
increasingly
affected
infertility.
ultimate
goal
reconcile
delicate
balance
molecular
concentration
their
concerted
effects
after
temporal
exposure
vivo.
We
aim
appraise
functions
relevance
as
diagnostic
biomarkers
value
additives
refine
strategies,
biotechnologies,
livestock
models
humans.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(8), P. 2042 - 2042
Published: July 29, 2023
Exosome-based
drug
delivery
is
emerging
as
a
promising
field
with
the
potential
to
revolutionize
therapeutic
interventions.
Exosomes,
which
are
small
extracellular
vesicles
released
by
various
cell
types,
have
attracted
significant
attention
due
their
unique
properties
and
natural
ability
transport
bioactive
molecules.
These
nano-sized
vesicles,
ranging
in
size
from
30
150
nm,
can
effectively
variety
of
cargoes,
including
proteins,
nucleic
acids,
lipids.
Compared
traditional
systems,
exosomes
exhibit
biocompatibility,
low
immunogenicity,
reduced
toxicity.
In
addition,
be
designed
tailored
improve
targeting
efficiency,
cargo
loading
capacity,
stability,
paving
way
for
personalized
medicine
precision
therapy.
However,
despite
exosome-based
delivery,
its
clinical
application
remains
challenging
limitations
exosome
isolation
purification,
efficiency
insufficient
targeted
rapid
elimination
circulation.
This
comprehensive
review
focuses
on
transition
bench
clinic,
highlighting
key
aspects,
such
structure
biogenesis,
methods,
surface
engineering
techniques,
applications.
It
also
discusses
challenges
prospects
this
field.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
155, P. 113690 - 113690
Published: Sept. 12, 2022
Severe
side
effects
of
chemotherapy
agents
on
vital
organs
are
the
major
causes
cancer-related
mortality,
not
merely
cancer
disease.
Encapsulating
chemotherapeutic
molecules
in
nanocarriers
is
a
justifiable
solution
decreasing
risk
their
and
boosting
efficiency
treatment.
The
present
study
has
developed
doxorubicin
(DOX)-loaded
AS1411
(anti-nucleolin)
aptamer
surface-functionalized
exosome
(DOX-Apt-Exo)
to
treat
colorectal
both
in-vitro
in-vivo
experimental
models.
HEK293-derived
exosomes
were
loaded
with
DOX
through
incubation
method
nearly
13%
encapsulation
efficiency.
Afterwards,
5-terminal
carboxyl
group
AS1411-aptamer
was
converted
into
amine-reactive
NHS
esters
EDC/NHS
amide
coupling
chemistry
before
being
conjugated
amine
groups
surface.
DLS
TEM
estimated
designed
formulation
size
about
200
nm.
Aptamer-binding
affinity
cellular
uptake
DOX-Apt-Exo
by
nucleolin-overexpressing
cells
depicted
fluorescence
microscopy.
Comparing
cytotoxicity
impact
DOX-loaded
exosomes,
either
targeted
or
non-targeted
MTT
assay,
clearly
verified
high
effectiveness
ligand-receptor
mediated
target
therapy.
Subsequently,
experiments
which
conducted
four
ectopic
mouse
models
colon
(5
each
group)
demonstrated
tumor
growth
suppression
professional
long-term
accumulation
retention
at
site
interaction.
results
suggested
that
aptamer-functionalized
can
be
recommended
as
safe
effective
system
site-specific
drug
delivery
possible
clinical
applications
cancer.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(1), P. 123 - 123
Published: Jan. 7, 2024
Lung
cancer
demands
innovative
approaches
for
early
detection
and
targeted
treatment.
In
addressing
this
urgent
need,
exosomes
play
a
pivotal
role
in
revolutionizing
both
the
treatment
of
lung
cancer.
Their
remarkable
capacity
to
encapsulate
diverse
range
biomolecules,
traverse
biological
barriers,
be
engineered
with
specific
targeting
molecules
makes
them
highly
promising
diagnostic
markers
precise
drug
delivery
cells.
Furthermore,
an
in-depth
analysis
exosomal
content
biogenesis
offers
crucial
insights
into
molecular
profile
tumors.
This
knowledge
holds
significant
potential
development
therapies
strategies
Despite
notable
progress
field,
challenges
standardization
cargo
loading
persist.
Collaborative
research
efforts
are
imperative
maximize
advance
field
precision
medicine
benefit
patients.
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
12(9), P. 2236 - 2252
Published: Jan. 1, 2024
Plant-derived
exosomes
(PDEs)
show
promising
potential
to
be
developed
as
a
therapeutic
agent
against
cancer,
owing
their
multiple
advantages
such
low
toxicity,
biocompatibility,
availability,
affordability,
etc.